2020-127-000-025 Fourniture de médicaments pouvant faire l objet d une mise en concurrence
Buyer: GIP RESAH
- Published
- 24 July 2024
- Estimated value
- €1,431,172
- Procedure
- Open procedure
- Notice number
- 00444249-2024
- Reference
- ae29fa0a-123e-4592-b576-0f0a46562820
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
2020-127-000-025 Fourniture de médicaments pouvant faire l objet d une mise en concurrence
Lots (15)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | 1 - A11DA01 - VITAMINE B1 (THIAMINE) ORAL | 33600000 Productos farmacéuticos | €465,099 |
| 2 | 2 - A11HA02 - VITAMINE B6 (PYRIDOXINE) ORAL | 33600000 Productos farmacéuticos | €325,030 |
| 3 | 3 - B01AE07 - DABIGATRAN - FORME ORALE | 33600000 Productos farmacéuticos | €74,041 |
| 4 | 4 - L01AD01 - CARMUSTINE - INJECTABLE | 33600000 Productos farmacéuticos | €771 |
| 5 | 5 - L01BB06 - CLOFARABINE - INJECTABLE | 33600000 Productos farmacéuticos | €189 |
| 6 | 6 - L01EB02 - ERLOTINIB - FORME ORALE | 33600000 Productos farmacéuticos | €1,823 |
| 7 | 7 - L03AX16 - PLERIXAFOR - INJECTABLE | 33600000 Productos farmacéuticos | €311 |
| 8 | 8 - L04AA23 - NATALIZUMAB - INJECTABLE | 33600000 Productos farmacéuticos | €2,000 |
| 9 | 9 - L04AA25 - ECULIZUMAB - INJECTABLE (indication Syndrome hémolytique urémique) | 33600000 Productos farmacéuticos | €1,594 |
| 10 | 10 - L04AC07 - TOCILIZUMAB 20 MG/ML - INJECTABLE | 33600000 Productos farmacéuticos | €3,820 |
| 11 | 11 - L04AX06 - POMALIDOMIDE - FORME ORALE | 33600000 Productos farmacéuticos | €38,586 |
| 12 | 12 - R03BB04 - TIOTROPIUM | 33600000 Productos farmacéuticos | €90,619 |
| 13 | 13 - J01DH03 - ERTAPENEM - INJECTABLE | 33600000 Productos farmacéuticos | €11,674 |
| 14 | 14 - B01AX06 - RIVAROXABAN - FORME ORALE | 33600000 Productos farmacéuticos | €409,241 |
| 15 | 15 - V04CH02 - CARMIN INDIGO - INJECTABLE | 33600000 Productos farmacéuticos | €6,374 |
Award criteria
- Price — Les critères et les sous-critères sont énoncés dans le règlement de la consultation.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| DB PHARMA | — | — |
| LABORATOIRES THERANOL DEGLAUDE | — | — |
| BOEHRINGER INGELHEIM Fr | — | — |
| BOEHRINGER INGELHEIM Fr | — | — |
| MEDIPHA SANTE SAS | — | — |
| BIOGARAN | — | — |
| SANOFI WINTHROP INDUSTRIE | — | — |
| SANDOZ | — | — |
| viatris | — | — |
| viatris | — | — |
Official publications
- TED · 00444249-2024 · 24 July 2024
- OJS · 143/2024 · 24 July 2024
Other tenders from GIP RESAH
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is €1,431,172.
- Who is the buyer of this tender?
- The contracting authority is GIP RESAH (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.